Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2010

01.03.2010 | Original Article

A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome

verfasst von: Imran Akhtar Siddiqui, Waleed Tamimi, Hani Tamim, Nada AlEisa, Maysoon Adham

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Polycystic ovary syndrome (PCOS) is an endocrine metabolic dysfunction closely associated with obesity, which predisposes to pregnancy complications. PCOS is a common endocrine disorder affecting 5–10% of the population. It is characterized by chronic anovulation and hyperandrogenism with clinical manifestations of oligomenorrhea, hirsutism and acne. Obese females are at higher risk for metabolic syndrome due to severe hyperandrogenemia, which also leads to high blood pressure.

Objectives

To determine, among patients with PCOS, the correlation of body mass index (BMI) with (1) the clinical manifestations of PCOS and (2) blood pressure.

Method

We performed a cross-sectional study of 62 women of reproductive age (29–43 years), who attended the Obstetrics and Gynecology Clinic at King Fahd National Guard Hospital in Riyadh, Kingdom of Saudi Arabia, with the confirmed diagnosis of PCOS. These patients were divided into two BMI groups: nonobese (BMI less than 25 kg/m2) and obese (BMI more than 25 kg/m2). Patients’ waist to hip ratio, acne, hirsutism, and systolic and diastolic blood pressures were also recorded as clinical manifestations in PCOS and compared between the two BMI groups.

Results

The mean age of the patients was 35.85 ± 5.03 years, BMI was 31.91 ± 6.40 kg/m2, waist–hip ratio was 0.82 ± 0.067, Ferriman and Gallway’s score for hirsutism was 3.63 ± 4.35, systolic blood pressure was 113.02 ± 16.10 mmHg, diastolic blood pressure was 71.79 ± 10.04 mmHg, and acne was present in 24 cases (38.7%). When the groups were compared according to BMI, a significant increase in systolic and diastolic blood pressures (p = 0.001 and 0.003, respectively) was seen in obese patients, but there was no significant rise in the waist–hip ratio and hirsutism score.

Conclusion

We observed a significant and progressive effect of BMI on clinical manifestations and blood pressure levels in patients with PCOS.
Literatur
1.
Zurück zum Zitat Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83(9):3078–3082. doi:10.1210/jc.83.9.3078 CrossRefPubMed Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83(9):3078–3082. doi:10.​1210/​jc.​83.​9.​3078 CrossRefPubMed
2.
Zurück zum Zitat Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84(11):4006–4011. doi:10.1210/jc.84.11.4006 CrossRefPubMed Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84(11):4006–4011. doi:10.​1210/​jc.​84.​11.​4006 CrossRefPubMed
3.
Zurück zum Zitat Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85(7):2434–2438. doi:10.1210/jc.85.7.2434 Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85(7):2434–2438. doi:10.​1210/​jc.​85.​7.​2434
4.
Zurück zum Zitat Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749. doi:10.1210/jc.2003-032046 CrossRefPubMed Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749. doi:10.​1210/​jc.​2003-032046 CrossRefPubMed
6.
Zurück zum Zitat Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447CrossRefPubMed Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447CrossRefPubMed
8.
Zurück zum Zitat Richardson MR (2003) Current perspectives in polycystic ovary syndrome. Am Fam Physician 68:697–704PubMed Richardson MR (2003) Current perspectives in polycystic ovary syndrome. Am Fam Physician 68:697–704PubMed
9.
Zurück zum Zitat Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F (2008) Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 23(1):153–159. doi:10.1093/humrep/dem356 CrossRefPubMed Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F (2008) Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 23(1):153–159. doi:10.​1093/​humrep/​dem356 CrossRefPubMed
10.
Zurück zum Zitat Macut D, Panidis D, Glisić B, Spanos N, Petakov M, Bjekić J, Stanojlović O, Rousso D, Kourtis A, Bozić I, Damjanović S (2008) Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharmacol 86(4):199–204. doi:10.1139/Y08-014 CrossRefPubMed Macut D, Panidis D, Glisić B, Spanos N, Petakov M, Bjekić J, Stanojlović O, Rousso D, Kourtis A, Bozić I, Damjanović S (2008) Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharmacol 86(4):199–204. doi:10.​1139/​Y08-014 CrossRefPubMed
11.
Zurück zum Zitat Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB (2008) Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 23(6):1431–1438. doi:10.1093/humrep/den090 CrossRefPubMed Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB (2008) Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 23(6):1431–1438. doi:10.​1093/​humrep/​den090 CrossRefPubMed
13.
14.
Zurück zum Zitat Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J (2000) Increased risk of non-insulin-dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15(4):785–789. doi:10.1093/humrep/15.4.785 CrossRefPubMed Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J (2000) Increased risk of non-insulin-dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15(4):785–789. doi:10.​1093/​humrep/​15.​4.​785 CrossRefPubMed
15.
Zurück zum Zitat Barcellos CR, Rocha MP, Hayashida SA, Mion Junior D, Lage SG, Marcondes JA (2007) Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 51(7):1104–1109. doi:10.1590/S0004-27302007000700013 PubMed Barcellos CR, Rocha MP, Hayashida SA, Mion Junior D, Lage SG, Marcondes JA (2007) Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 51(7):1104–1109. doi:10.​1590/​S0004-2730200700070001​3 PubMed
16.
Zurück zum Zitat Goldzieher JW (1981) Polycystic ovarian disease. Clin Fertil Steril 35(4):371–394 Goldzieher JW (1981) Polycystic ovarian disease. Clin Fertil Steril 35(4):371–394
18.
Zurück zum Zitat Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10(8):2107–2111PubMed Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10(8):2107–2111PubMed
19.
Zurück zum Zitat Haq F, Aftab O, Rizvi J (2007) Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome. J Coll Physicians Surg Pak 17(2):76–80PubMed Haq F, Aftab O, Rizvi J (2007) Clinical, biochemical and ultrasonographic features of infertile women with polycystic ovarian syndrome. J Coll Physicians Surg Pak 17(2):76–80PubMed
20.
Zurück zum Zitat Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI (2008) Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(3):999–1004. doi:10.1210/jc.2007-2117 CrossRefPubMed Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI (2008) Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(3):999–1004. doi:10.​1210/​jc.​2007-2117 CrossRefPubMed
22.
Zurück zum Zitat Taponen S, Ahonkallio S, Martikainen H, Koivunen R, Ruokonen A, Sovio U, Hartikainen AL, Pouta A, Laitinen J, King V, Franks S, McCarthy MI, Järvelin MR (2004) Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 19(5):1083–1088. doi:10.1093/humrep/deh214 CrossRefPubMed Taponen S, Ahonkallio S, Martikainen H, Koivunen R, Ruokonen A, Sovio U, Hartikainen AL, Pouta A, Laitinen J, King V, Franks S, McCarthy MI, Järvelin MR (2004) Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 19(5):1083–1088. doi:10.​1093/​humrep/​deh214 CrossRefPubMed
23.
Zurück zum Zitat Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545–2549. doi:10.1210/jc.2004-2279 CrossRefPubMed Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA (2005) Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90(5):2545–2549. doi:10.​1210/​jc.​2004-2279 CrossRefPubMed
24.
Zurück zum Zitat Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O’Keefe M, Ghazzi MN (2001) Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86(4):1626–1632. doi:10.1210/jc.86.4.1626 CrossRefPubMed Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O’Keefe M, Ghazzi MN (2001) Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86(4):1626–1632. doi:10.​1210/​jc.​86.​4.​1626 CrossRefPubMed
25.
Zurück zum Zitat Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, Schlaff WD, Coutifaris C, McGovern PG, Cataldo NA, Steinkampf MP, Nestler JE, Gosman G, Guidice LC, Leppert PC (2006) The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86(4):914–933. doi:10.1016/j.fertnstert.2006.03.037 CrossRefPubMed Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, Schlaff WD, Coutifaris C, McGovern PG, Cataldo NA, Steinkampf MP, Nestler JE, Gosman G, Guidice LC, Leppert PC (2006) The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86(4):914–933. doi:10.​1016/​j.​fertnstert.​2006.​03.​037 CrossRefPubMed
27.
Zurück zum Zitat Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88(10):4682–4688. doi:10.1210/jc.2003-030617 CrossRefPubMed Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88(10):4682–4688. doi:10.​1210/​jc.​2003-030617 CrossRefPubMed
29.
Metadaten
Titel
A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome
verfasst von
Imran Akhtar Siddiqui
Waleed Tamimi
Hani Tamim
Nada AlEisa
Maysoon Adham
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2010
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-009-1124-y

Weitere Artikel der Ausgabe 3/2010

Archives of Gynecology and Obstetrics 3/2010 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.